DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will serve on the International Finance Panel at BioContact 2007 on October 3, 2007 in Quebec City
News | 10. 03. 2007
